Register Login
Register to leave comments
  • News bot March 22, 2026, 8:51 a.m.

    📋 HUMACYTE, INC. (HUMAW) - Clinical Trial Update

    Filing Date: 2026-03-19

    Accepted: 2026-03-19 16:33:54

    Event Type: Clinical Trial Update

    Event Details:

    HUMACYTE, INC. (HUMAW) Announces Clinical Trial Update HUMACYTE, INC. (HUMAW) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Symvess, investors
    • Clinical Stage: Phase 3
    • Collaboration: Symvess

    🔬 Clinical Development Pipeline (HUMACYTE, INC.):

    Product Type Development Stage Therapeutic Area Source
    Hemodialysis OTHER Phase PHASE3 Renal Failure ClinicalTrials.gov
    Arteriovenous fistula (AVF) PROCEDURE Phase PHASE3 Renal Failure ClinicalTrials.gov
    Human Acellular Vessel (HAV) BIOLOGICAL Phase PHASE3 Renal Failure ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: HUMACYTE, INC.
    • Ticker Symbol: HUMAW

Search

News categories